BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 33868304)

  • 1. The Diverse Roles of Heme Oxygenase-1 in Tumor Progression.
    Luu Hoang KN; Anstee JE; Arnold JN
    Front Immunol; 2021; 12():658315. PubMed ID: 33868304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heme oxygenase-1 orchestrates the immunosuppressive program of tumor-associated macrophages.
    Alaluf E; Vokaer B; Detavernier A; Azouz A; Splittgerber M; Carrette A; Boon L; Libert F; Soares M; Le Moine A; Goriely S
    JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme oxygenase-1 in tumors: is it a false friend?
    Jozkowicz A; Was H; Dulak J
    Antioxid Redox Signal; 2007 Dec; 9(12):2099-117. PubMed ID: 17822372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages.
    Kim SH; Saeidi S; Zhong X; Gwak SY; Muna IA; Park SA; Kim SH; Na HK; Joe Y; Chung HT; Kim KE; Han W; Surh YJ
    Neoplasia; 2020 Nov; 22(11):606-616. PubMed ID: 33039895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme oxygenase-1 in tumor biology and therapy.
    Was H; Dulak J; Jozkowicz A
    Curr Drug Targets; 2010 Dec; 11(12):1551-70. PubMed ID: 20704546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1.
    Na HK; Surh YJ
    Free Radic Biol Med; 2014 Feb; 67():353-65. PubMed ID: 24200599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
    Balta E; Wabnitz GH; Samstag Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression, function and targeting of haem oxygenase-1 in cancer.
    Hjortsø MD; Andersen MH
    Curr Cancer Drug Targets; 2014; 14(4):337-47. PubMed ID: 24655000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment.
    Laha D; Grant R; Mishra P; Nilubol N
    Front Immunol; 2021; 12():656908. PubMed ID: 33986746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme catabolism by tumor-associated macrophages controls metastasis formation.
    Consonni FM; Bleve A; Totaro MG; Storto M; Kunderfranco P; Termanini A; Pasqualini F; Alì C; Pandolfo C; Sgambelluri F; Grazia G; Santinami M; Maurichi A; Milione M; Erreni M; Doni A; Fabbri M; Gribaldo L; Rulli E; Soares MP; Torri V; Mortarini R; Anichini A; Sica A
    Nat Immunol; 2021 May; 22(5):595-606. PubMed ID: 33903766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the monocyte/macrophage system in heart failure by targeting heme oxygenase-1.
    Tomczyk M; Kraszewska I; Dulak J; Jazwa-Kusior A
    Vascul Pharmacol; 2019 Jan; 112():79-90. PubMed ID: 30213580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HO-1/CO system in tumor growth, angiogenesis and metabolism - Targeting HO-1 as an anti-tumor therapy.
    Loboda A; Jozkowicz A; Dulak J
    Vascul Pharmacol; 2015 Nov; 74():11-22. PubMed ID: 26392237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme oxygenase-1: emerging target of cancer therapy.
    Chau LY
    J Biomed Sci; 2015 Mar; 22(1):22. PubMed ID: 25885228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The macrophage heme-heme oxygenase-1 system and its role in inflammation.
    Vijayan V; Wagener FADTG; Immenschuh S
    Biochem Pharmacol; 2018 Jul; 153():159-167. PubMed ID: 29452096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2 tumor-associated macrophages resist to oxidative stress through heme oxygenase-1 in the colorectal cancer tumor microenvironment.
    Ito M; Mimura K; Nakajima S; Okayama H; Saito K; Nakajima T; Kikuchi T; Onozawa H; Fujita S; Sakamoto W; Saito M; Momma T; Saze Z; Kono K
    Cancer Immunol Immunother; 2023 Jul; 72(7):2233-2244. PubMed ID: 36869896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Dual Role of Heme Oxygenase-1 in Cancer Cells.
    Chiang SK; Chen SE; Chang LC
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential.
    Paine A; Eiz-Vesper B; Blasczyk R; Immenschuh S
    Biochem Pharmacol; 2010 Dec; 80(12):1895-903. PubMed ID: 20643109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual role and mutual dependence of heme/HO-1/Bach1 axis in the carcinogenic and anti-carcinogenic intersection.
    Xu J; Zhu K; Wang Y; Chen J
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):483-501. PubMed ID: 36310300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR4 activation alters labile heme levels to regulate BACH1 and heme oxygenase-1 expression in macrophages.
    Sudan K; Vijayan V; Madyaningrana K; Gueler F; Igarashi K; Foresti R; Motterlini R; Immenschuh S
    Free Radic Biol Med; 2019 Jun; 137():131-142. PubMed ID: 31026585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.